<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.0 20040730//EN" "archivearticle.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?OLF?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id><journal-id journal-id-type="publisher-id">pbio</journal-id><journal-title>PLoS Biology</journal-title><issn pub-type="ppub">1544-9173</issn><issn pub-type="epub">1545-7885</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.1371/journal.pbio.0030254</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject><subject>Cell Biology</subject><subject>Development</subject><subject>Genetics/Genomics/Gene Therapy</subject><subject>Hematology</subject><subject>Danio (Zebrafish)</subject><subject>Homo (Human)</subject></subj-group></article-categories><title-group><article-title>Functional Analysis of Human Hematopoietic Stem Cell Gene Expression Using Zebrafish</article-title><alt-title alt-title-type="running-head">Functional Analysis of HSC Gene Expression</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Eckfeldt</surname><given-names>Craig E</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Mendenhall</surname><given-names>Eric M</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Flynn</surname><given-names>Catherine M</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Tzu-Fei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pickart</surname><given-names>Michael A</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Grindle</surname><given-names>Suzanne M</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ekker</surname><given-names>Stephen C</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Verfaillie</surname><given-names>Catherine M</given-names></name><email>verfa001&#x00040;umn.edu</email><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><bold>1</bold> Department of Medicine, Division of Hematology, Oncology, and Transplantation, and Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, United States of America,</aff><aff id="aff2"><bold>2</bold> Genetics, Cell Biology, and Development and Arnold and Mabel Beckman Center for Transposon Research, University of Minnesota, Minneapolis, Minnesota, United States of America,</aff><aff id="aff3"><bold>3</bold> Cancer Center Bioinformatics Division, University of Minnesota, Minneapolis, Minnesota, United States of America</aff><contrib-group><contrib contrib-type="editor"><name><surname>Zon</surname><given-names>Leonard I.</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><institution>Harvard Medical School and Children's Hospital</institution><country>United States of America</country></aff><pub-date pub-type="ppub"><month>8</month><year>2005</year></pub-date><pub-date pub-type="epub"><day>5</day><month>7</month><year>2005</year></pub-date><volume>3</volume><issue>8</issue><elocation-id>e254</elocation-id><history><date date-type="received"><day>12</day><month>11</month><year>2004</year></date><date date-type="accepted"><day>14</day><month>5</month><year>2005</year></date></history><copyright-statement>Copyright: &#x000a9; 2005 Eckfeldt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</copyright-statement><copyright-year>2005</copyright-year><related-article related-article-type="companion" xlink:title="synopsis" xlink:href="10.1371/journal.pbio.0030279" vol="3" page="e279" id="N0x9797d98.0x977b788" ext-link-type="doi"><article-title>Fish and Chips: A Fast Track to Understanding Blood Development</article-title></related-article><abstract><p>Although several reports have characterized the hematopoietic stem cell (HSC) transcriptome, the roles of HSC-specific genes in hematopoiesis remain elusive. To identify candidate regulators of HSC fate decisions, we compared the transcriptome of human umbilical cord blood and bone marrow CD34<sup>+</sup>CD33<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup>Rho<sup>lo</sup>c-kit<sup>+</sup> cells, enriched for hematopoietic stem/progenitor cells with CD34<sup>+</sup>CD33<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup>Rho<sup>hi</sup> cells, enriched in committed progenitors. We identified 277 differentially expressed transcripts conserved in these ontogenically distinct cell sources. We next performed a morpholino antisense oligonucleotide (MO)-based functional screen in zebrafish to determine the hematopoietic function of 61 genes that had no previously known function in HSC biology and for which a likely zebrafish ortholog could be identified. MO knock down of 14/61 (23&#x00025;) of the differentially expressed transcripts resulted in hematopoietic defects in developing zebrafish embryos, as demonstrated by altered levels of circulating blood cells at 30 and 48 h postfertilization and subsequently confirmed by quantitative RT-PCR for erythroid-specific <italic>hbae1</italic> and myeloid-specific <italic>lcp1</italic> transcripts. Recapitulating the knockdown phenotype using a second MO of independent sequence, absence of the phenotype using a mismatched MO sequence, and rescue of the phenotype by cDNA-based overexpression of the targeted transcript for zebrafish <italic>spry4</italic> confirmed the specificity of MO targeting in this system. Further characterization of the <italic>spry4</italic>-deficient zebrafish embryos demonstrated that hematopoietic defects were not due to more widespread defects in the mesodermal development, and therefore represented primary defects in HSC specification, proliferation, and/or differentiation. Overall, this high-throughput screen for the functional validation of differentially expressed genes using a zebrafish model of hematopoiesis represents a major step toward obtaining meaningful information from global gene profiling of HSCs.</p></abstract><abstract abstract-type="toc"><p>Microarray studies are combined with a functional screen in zebrafish to identify new genes that are involved in the function and differentiation of hematopoietic stem cells.</p></abstract></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Hematopoiesis is the process by which hematopoietic stem cells (HSCs) give rise to all hematopoietic lineages during the lifetime of an individual. To sustain lifelong hematopoiesis, HSCs must self-renew to maintain or expand the HSC pool &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b01">1</xref>&#x0005d;, and they must differentiate to form committed hematopoietic progenitor cells (HPCs) that progressively lose self-renewal potential and become increasingly restricted in their lineage potential. A combination of extrinsic and intrinsic signals are thought to converge to regulate HSC differentiation <italic>versus</italic> self-renewal decisions, but the molecular mechanisms that regulate these processes are poorly understood &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b02">2</xref>&#x0005d;.</p><p>A multitude of cytokines have been cloned that affect HSCs and HPCs; however, to date none of these, alone or in combination, can induce the symmetrical, self-renewing HSC cell division in vitro that is required for HSC expansion. Recently, several novel regulators of HSC fate decisions have been identified. For instance, overexpression of <italic>Hoxb4</italic> results in expansion of murine and human HSCs with an increased competitive repopulation potential &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b03">3</xref>&#x02013;<xref ref-type="bibr" rid="pbio-0030254-b05">5</xref>&#x0005d;; novel extrinsic regulators implicated in self-renewal of HSCs include Notch &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b06">6</xref>&#x0005d;, Wnt &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b07">7</xref>,<xref ref-type="bibr" rid="pbio-0030254-b08">8</xref>&#x0005d;, and the morphogens, <italic>SHH</italic> (sonic hedgehog) &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b09">9</xref>&#x0005d; and <italic>BMP4</italic> (bone morphogenetic protein 4) &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b09">9</xref>&#x0005d;. While the discovery of these novel regulators provides credence to the hypothesis that extrinsic and intrinsic signals can influence HSC fate, a more global gene and/or protein expression analysis of human HSC should provide additional insight into pathways that support HSC self-renewal.</p><p>Our current understanding of the expressed gene profile of HSCs comes primarily from murine HSCs that can be purified to near homogeneity &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b10">10</xref>&#x02013;<xref ref-type="bibr" rid="pbio-0030254-b14">14</xref>&#x0005d;. The inability to purify human HSCs to similar degrees of homogeneity makes study of the transcriptome of human HSCs more difficult. Human HSCs and HPCs are CD34 positive, while cells that engraft in severe combined immunodeficiency (SCID) mice are enriched in the CD34<sup>+</sup>Lineage(Lin)<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup> fraction &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b15">15</xref>&#x0005d;. As fewer than 1/500 CD34<sup>+</sup>Lin<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup> cells can repopulate SCID mice &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b15">15</xref>&#x0005d;, the expressed gene profile of CD34<sup>+</sup>Lin<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup> cells is likely only partially enriched for HSC-specific genes &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b12">12</xref>,<xref ref-type="bibr" rid="pbio-0030254-b16">16</xref>&#x0005d;. We previously demonstrated that the rhodamine (Rho) 123<sup>&#x02212;</sup> and c-kit<sup>+</sup> subpopulation of CD34<sup>+</sup>Lin<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup> cells (Rho<sup>lo</sup>) cells are highly enriched for primitive HPCs with myeloid&#x02013;lymphoid initiating cell (ML&#x02013;IC) capacity relative to CD34<sup>+</sup>CD38<sup>&#x02212;</sup>CD33<sup>&#x02212;</sup>Rho<sup>hi</sup> (Rho<sup>hi</sup>) cells &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b17">17</xref>&#x0005d;. Thus, such selection separates CD34<sup>+</sup>Lin<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup> cells into HSC-enriched and HSC-depleted populations.</p><p>We hypothesized that comparison of the transcriptome of Rho<sup>lo</sup> and Rho<sup>hi</sup> cells from umbilical cord blood (UCB) and bone marrow (BM) should identify conserved genes and gene pathways that define the human HSC. Because of the inherent limitations of using gene expression data to infer biological gene function, we also assessed the hematopoietic role of these genes in a high-throughput in vivo functional genomics screen in the zebrafish. Using this strategy we have not only identified a series of genes that may represent novel regulators of human HSC fate decisions, but this work also represents, to our knowledge, the first example of a functional genetic screening strategy that is a critical step toward obtaining biologically relevant functional data from global gene-profiling studies.</p></sec><sec id="s2"><title>Results/Discussion</title><sec id="s2a"><title>ML&#x02013;ICs Are Highly Enriched in Rho<sup>lo</sup> Compared to Rho<sup>hi</sup> Cells</title><p>The study of human HSCs has been limited since the CD34<sup>+</sup>Lin<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup> fraction of hematopoietic cells, commonly used as an HSC-enriched population, contains fewer than 0.2&#x00025; SCID-repopulating cells &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b15">15</xref>&#x0005d;, suggesting considerable heterogeneity. We have shown that ML&#x02013;IC s, single hematopoietic cells that can generate several daughter cells capable of reinitiating long-term myeloid and long-term lymphoid cultures, are highly enriched by selecting the Rho<sup>lo</sup> fraction of CD34<sup>+</sup>Lin<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup> cells. While the Rho<sup>lo</sup> population still only contains 15&#x00025;&#x02013;25&#x00025; ML&#x02013;ICs and therefore remains heterogeneous, the enrichment factor is 5- to 10-fold greater than CD34<sup>+</sup>Lin<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup> cells &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b17">17</xref>&#x0005d;. Similar to our previous studies, the ML&#x02013;IC frequency was greater than or equal to 10-fold higher in UCB Rho<sup>lo</sup> compared to Rho<sup>hi</sup> cells (<xref ref-type="supplementary-material" rid="sg001">Figure S1</xref>).</p></sec><sec id="s2b"><title>Genes Differentially Expressed between Rho<sup>lo</sup> and Rho<sup>hi</sup> Cells from Both UCB and BM</title><p>We hypothesized that comparing genes differentially expressed between Rho<sup>lo</sup> and Rho<sup>hi</sup> cells from ontogenically distinct sources would identify conserved genes and gene pathways that govern self-renewal and differentiation of human HSCs. The experimental design used is illustrated in <xref ref-type="fig" rid="pbio-0030254-g001">Figure 1</xref>. We defined differentially expressed probe sets as those with <italic>p</italic> &#x0003c; 0.05, using a paired Student's <italic>t</italic>-test. By taking into account the variability present in primary cell populations, this provides a more accurate analysis of differential gene expression compared with the commonly used fold change cutoff.</p><p>We identified 2,707 and 4,667 probe sets differentially expressed between Rho<sup>lo</sup> and Rho<sup>hi</sup> cells from UCB and BM, respectively (see <xref ref-type="supplementary-material" rid="st001">Tables S1</xref> and <xref ref-type="supplementary-material" rid="st002">S2</xref>). The fidelity of our microarray results was confirmed using quantitative RT-PCR (Q-RT-PCR) (see <xref ref-type="supplementary-material" rid="sg002">Figure S2</xref>). We focused our further analysis on 277 unique transcripts, represented by 304 probe sets that were differentially expressed between Rho<sup>lo</sup> and Rho<sup>hi</sup> cells from both UCB and BM with a fold change greater than 1.5 in either UCB or BM (<xref ref-type="supplementary-material" rid="st003">Table S3</xref>).</p><p>Among the conserved genes enriched in Rho<sup>lo</sup> cells, many have been implicated in early hematopoiesis, including <italic>CDKN1A</italic>, a cell cycle regulator required for maintenance of murine HSCs &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b18">18</xref>&#x0005d;, and <italic>ABCB1</italic>, the ABC-transporter family member responsible for the Rho<sup>lo</sup> phenotype &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b17">17</xref>&#x0005d;. Several transcription factors (TFs) known to play a role in early hematopoiesis or leukemogenesis were also identified, including <italic>HLF</italic>, involved in leukemogenic chromosomal translocations &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b19">19</xref>&#x0005d; and <italic>EVI1</italic>, a TF associated with myeloid leukemias &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b20">20</xref>&#x0005d;. Other TFs without a known role in hematopoiesis were also more highly expressed in Rho<sup>lo</sup> cells, including <italic>HMGA2</italic>, a high-mobility group gene, and the zinc finger TFs <italic>ZNF165</italic>, <italic>ZNF331</italic>, and <italic>KLF5</italic>. All Rho<sup>lo</sup>-enriched genes are listed in <xref ref-type="supplementary-material" rid="st003">Table S3</xref>. As demonstrated in previous HSC gene-profiling studies &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b12">12</xref>&#x02013;<xref ref-type="bibr" rid="pbio-0030254-b14">14</xref>&#x0005d;, more than 40&#x00025; of genes enriched in Rho<sup>lo</sup> cells lack a functional annotation, are hypothetical proteins, or are expressed sequence tags, and thus may represent currently uncharacterized regulators of HSC fate decisions (<xref ref-type="supplementary-material" rid="sg003">Figure S3</xref>).</p><p>Some genes with well-established roles in HSC self-renewal and early differentiation are not present in the Rho<sup>lo</sup> enriched gene list. However, most of these were differentially expressed in both datasets, but differences did not reach statistical significance. For instance, <italic>LMO2</italic> &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b21">21</xref>&#x0005d; and <italic>GATA</italic><italic>2</italic> &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b22">22</xref>&#x0005d;, known to be involved in HSC development and self-renewal, were expressed significantly higher in BM Rho<sup>lo</sup> than in Rho<sup>hi</sup> cells. Although similar trends were seen in UCB Rho<sup>lo</sup> cells, these differences were not statistically significant (<xref ref-type="supplementary-material" rid="st004">Table S4</xref>). Conversely, <italic>HOXB4</italic> &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b04">4</xref>&#x0005d; expression was significantly higher in UCB Rho<sup>lo</sup> than in Rho<sup>hi</sup> cells, but this difference was not statistically significant in BM. Although our stringent criteria for differential expression likely contribute to the omission of some genes that might be differentially expressed, another explanation might be that expression of these genes is maintained when cells differentiate from a Rho<sup>lo</sup> to a Rho<sup>hi</sup> stage. The latter is consistent with the fact that most known HSC-associated genes were expressed at much higher levels than the normalized average microarray expression level in Rho<sup>lo</sup> and in Rho<sup>hi</sup> cells from both UCB and BM (<xref ref-type="supplementary-material" rid="st004">Table S4</xref>).</p><p>Conserved genes enriched in the Rho<sup>hi</sup> cells included <italic>LEF1</italic>, an effector of Wnt signaling expressed in pre-B and T cells &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b23">23</xref>&#x0005d;, and <italic>NOTCH2</italic>, involved in hematopoietic differentiation cell-fate decision &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b24">24</xref>&#x0005d;. Several TFs known to play a role in hematopoietic cell differentiation were more highly expressed in Rho<sup>hi</sup> compared to Rho<sup>lo</sup> cells, including <italic>HELLS</italic> and <italic>MAFB</italic> &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b25">25</xref>,<xref ref-type="bibr" rid="pbio-0030254-b26">26</xref>&#x0005d;. Additional TFs with no known role in hematopoietic development were also enriched in Rho<sup>hi</sup> cells, such as the zinc finger homeobox gene, <italic>ZFHX1B</italic> and the polycomb genes, <italic>EZH2</italic> and <italic>SUZ12</italic>, the latter required for germ cell development &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b27">27</xref>&#x0005d;. Globin <italic>(Hb)</italic> gene family members were also more highly expressed in UCB and BM Rho<sup>hi</sup> than in Rho<sup>lo</sup> cells. Consistent with the ontogenic expression patterns of fetal <italic>versus</italic> adult <italic>Hb</italic> genes, <italic>Hb&#x003b3;</italic> genes were more highly expressed in perinatal UCB Rho<sup>hi</sup> cells, while <italic>Hb&#x003b2;</italic> genes were more highly expressed in adult BM Rho<sup>hi</sup> cells. Additional genes enriched in Rho<sup>hi</sup> cells are listed in <xref ref-type="supplementary-material" rid="st003">Table S3</xref>.</p><p>Because of functional redundancy among gene families, we examined the data for common differentially expressed gene family members. The Id family of transcriptional repressors &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b28">28</xref>&#x0005d; was enriched in the Rho<sup>lo</sup> fraction, but was represented by different family members in UCB <italic>(ID4)</italic> and BM <italic>(ID1</italic>, <italic>ID2</italic>, and <italic>ID3).</italic> Similarly, various H1 and H2 histone genes were enriched in the Rho<sup>lo</sup> fraction in both datasets, but were represented by distinct family members.</p><p>We also evaluated whether common differentially expressed genes were concentrated on specific chromosomes. We found that genes were not only concentrated on certain chromosomes, but at specific g-band addresses. Of the genes enriched in Rho<sup>lo</sup> cells, 9&#x00025; reside at 6p21, a region involved in recurrent chromosomal translocations in myeloid &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b29">29</xref>&#x0005d; and lymphoid &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b30">30</xref>&#x0005d; leukemias, and home to the <italic>PIM1</italic> oncogene &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b31">31</xref>&#x0005d;. Six members of the H2B and one member of the H1 histone family, as well as <italic>CDKN1A</italic>, more highly expressed in Rho<sup>lo</sup> than Rho<sup>hi</sup> cells, reside at 6p21. The remaining Rho<sup>lo</sup>-enriched genes at 6p21 consist of six class II major histocompatibility complex (MHC) family members and a putative testis-specific zinc finger TF, <italic>ZNF165</italic>. H1 and H2 histone gene family members &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b11">11</xref>,<xref ref-type="bibr" rid="pbio-0030254-b13">13</xref>&#x0005d;, class II MHC antigens &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b12">12</xref>,<xref ref-type="bibr" rid="pbio-0030254-b13">13</xref>&#x0005d;, and <italic>CDKN1A</italic> &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b13">13</xref>&#x0005d; were also found among the genes identified in studies characterizing the transcriptome of murine HSC. The differential expression of such a large number of genes located at this chromosomal address suggests that, like <italic>CDKN1A</italic>, other genes located at 6p21 with as yet unknown hematopoietic function may play a role in HSC proliferation or differentiation.</p><p>We also compared the genes expressed more highly in Rho<sup>lo</sup><italic>versus</italic> Rho<sup>hi</sup> cells with published gene expression data. Comparison with the study by Ivanova et al. &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b12">12</xref>&#x0005d; that compared human CD34<sup>+</sup>Lin<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup> with CD34<sup>+</sup>Lin<sup>&#x02212;</sup>CD38<sup>+</sup> cells, yielded only seven genes in common: <italic>ARMCX2</italic>, <italic>CRYGD, HLF</italic>, <italic>KIAA1102</italic>, <italic>RBPMS</italic>, <italic>SLCO3A1</italic>, and <italic>SSBP2</italic>. The lack of overlap may not be that surprising as Rho<sup>lo</sup> and Rho<sup>hi</sup> cells are subpopulations of the CD34<sup>+</sup>Lin<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup> population used by Ivanova et al. Comparison of genes expressed more highly in Rho<sup>lo</sup><italic>versus</italic> Rho<sup>hi</sup> cells with genes expressed more highly in murine side population/KLS/CD34<sup>&#x02212;</sup> compared to total BM cells published by Ramalho-Santos et al. &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b13">13</xref>&#x0005d; identified 16 likely orthologs and 38 common gene family members (<xref ref-type="supplementary-material" rid="st005">Table S5</xref>), suggesting that HSC-specific genes are conserved across species.</p><sec id="s2b1"><title>In vivo functional genomics screen in zebrafish</title><p>Because gene profiling per se does not prove functional importance, we developed an in vivo functional genomics screen in zebrafish (<xref ref-type="fig" rid="pbio-0030254-g002">Figure 2</xref>). The zebrafish, <italic>Danio rerio</italic>, is an ideal organism for high-throughput genetic screens &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b32">32</xref>&#x0005d; as organogenesis is highly conserved from zebrafish to man &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b33">33</xref>&#x0005d;. There is abundant evidence that hematopoiesis in zebrafish occurs via a highly conserved genetic program. As in mammals, hematopoiesis in zebrafish occurs via specification of mesoderm to a hemangioblast stage that subsequently commits to either HSC or angioblasts &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b34">34</xref>&#x0005d;, and genes and signals involved in specification (BMP signaling) and commitment (vascular endothelial growth factor signaling; <italic>flk1</italic>, also known as <italic>kdr; lmo2; scl</italic>, also known as <italic>tal1; gata2;</italic><italic>gata1</italic>) are conserved from fish to man &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b35">35</xref>&#x0005d;. This high degree of homology in the genetic control of zebrafish and human hematopoietic development makes genetic screens in zebrafish a powerful tool to elucidate the role of genes in hematopoiesis. Additionally, rapid reverse genetic screens can be accomplished using morpholino antisense oligonucleotides (MOs) to knock down gene expression in the developing zebrafish embryo &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b36">36</xref>&#x0005d;.</p><p>From the 277 unique transcripts that were differentially expressed between Rho<sup>lo</sup> and Rho<sup>hi</sup> cells of both UCB and BM (<xref ref-type="supplementary-material" rid="st003">Table S3</xref>), we eliminated genes with known function in hematopoiesis, MHC genes, histones, and genes that are known to play a role in glucose and protein metabolism and RNA and DNA synthesis, resulting in a final list of 158 genes. Of these, we identified a putative zebrafish ortholog for 86, and designed MOs against 61 (<xref ref-type="supplementary-material" rid="st006">Table S6</xref>). The 61 MOs were injected in one- to two-cell zebrafish embryos and assayed for effects on blood development. Initial dosing studies identified 16/61 MOs that reduce blood cell production without confounding toxicities (<xref ref-type="table" rid="pbio-0030254-t001">Table 1</xref>). The 16 MOs induced a blood defect in more than 70&#x00025; of embryos in two or more independent injections. Blood defects identified by <italic>gata1:</italic>DsRed transgenic (Tg) fluorescence microscopy were confirmed by Q-RT-PCR of the erythroid-specific <italic>hbae1</italic> and myeloid-specific <italic>lcp1</italic> transcripts in MO-targeted embryos compared to uninjected controls in three or more independent experiments of <italic>n</italic> = 5 embryos per experiment. A greater than 2-fold reduction in both erythroid and myeloid gene expression levels were seen for five of seven MOs analyzed (see <xref ref-type="table" rid="pbio-0030254-t001">Table 1</xref>; <xref ref-type="fig" rid="pbio-0030254-g003">Figures 3</xref> and <xref ref-type="fig" rid="pbio-0030254-g004">4</xref>). Thus, the addition of Q-RT-PCR to the screening process provides an independent confirmation and quantitation of the observed phenotypes, thereby limiting the false-positive rate, while maintaining the high-throughput nature of the screen. Additionally, the observed reduction of both erythroid and myeloid gene expression following knockdown of candidate genes is consistent with their presumed roles in HSC fate decisions prior to specification of the common myeloid progenitor. The validity of the Q-RT-PCR analysis was corroborated by analysis of <italic>hbae1</italic> and <italic>lcp1</italic> transcript levels in <italic>gata1</italic> MO-targeted embryos, in which there was a virtually complete loss of <italic>hbae1</italic> expression and an almost 2-fold increase in myeloid-specific <italic>lcp1</italic> transcripts (<xref ref-type="fig" rid="pbio-0030254-g004">Figure 4</xref>) consistent with the published expression patterns for these genes following loss of <italic>gata1</italic> expression &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b37">37</xref>&#x0005d;. Analysis of vascular development by injecting MOs into <italic>fli1:</italic>enhanced green fluorescent protein (EGFP) Tg embryos, which express EGFP in endothelial cells, demonstrated no major abnormalities in vascular morphogenesis or remodeling that precludes the circulation of the remaining blood cells, indicating that the hematopoietic defect is not secondary to a vascular phenotype (<xref ref-type="fig" rid="pbio-0030254-g004">Figure 4</xref>; <xref ref-type="supplementary-material" rid="st007">Table S7</xref>).</p><p>The greater than 20&#x00025; frequency of blood defects seen in our screen compares very favorably with the 0.5&#x00025;&#x02013;1&#x00025; frequency of hematopoietic phenotypes seen by ethylnitrosourea mutagenesis screens that mutate genes in a near random fashion &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b38">38</xref>&#x0005d; and the 4&#x00025; of hematopoietic phenotypes seen in a morpholino-based functional screen of the zebrafish secretome &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b39">39</xref>&#x0005d; (S. C. Ekker, unpublished data). The high incidence of blood defects also demonstrates that the candidate genes identified by comparing the transcriptome of Rho<sup>lo</sup> and Rho<sup>hi</sup> cells represent genes with important roles in HSC biology. We were unable to identify a candidate ortholog in zebrafish for 72/158 of the differentially expressed human genes. This may be because currently only one quarter of the zebrafish genome is high-quality finished sequence. Hence, some genes with important roles in hematopoiesis may have been untested. However, from a sample of ten genes that lacked a zebrafish match, only one has a likely ortholog in the Fugu or Medaka sequencing projects, and thus incomplete genome coverage provides only a partial explanation. Alternative possibilities include a reduced level of primary sequence conservation between functional orthologs that would have been missed using our simple comparative genomics criteria, or that a number of genes are not conserved between fish and man, and thus might be less important for the conserved processes of hematopoietic self-renewal and differentiation. Therefore, the relatively high incidence of blood defects in conserved genes may in part reflect &#x0201c;evolutionary filtering&#x0201d; in our screen. Consistent with this hypothesis, all zebrafish genes whose mutation resulted in a visible embryonic phenotype identified using a retroviral insertion strategy have a likely human ortholog &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b40">40</xref>&#x0005d;.</p><p>Although the frequency of blood defects is high, the screen is not as well suited for the identification of knockdown phenotypes that result in increased HSC proliferation and/or differentiation. We and others have successfully shown that dramatically increased hematopoietic development can be modeled in zebrafish, as is the case for knockdown of the BMP-antagonist <italic>chd (chordin)</italic> and the corresponding <italic>dino</italic> mutant &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b41">41</xref>,<xref ref-type="bibr" rid="pbio-0030254-b42">42</xref>&#x0005d;; however, more modest increases in hematopoietic cell production or skewing of lineage differentiation may be undetectable. Although these caveats may lead to underestimation of the true frequency of genes with a role in early hematopoietic development and differentiation, the screening procedure used has proven effective for extracting functional information from a global gene expression profiling dataset in a high-throughput manner.</p><p>Of note, viable knockout mice exist for 4/14 genes identified in our functional screen <italic>(Sparc, Irak3, Ccr7</italic>, and <italic>Prkch)</italic> &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b43">43</xref>&#x02013;<xref ref-type="bibr" rid="pbio-0030254-b46">46</xref>&#x0005d;. One could argue that if a viable knockout mouse exists, the gene of interest may not be important in hematopoiesis. However, lack of an overt hematopoietic phenotype does not preclude a role of a gene in HSC self-renewal and differentiation, as this may only be detectable under conditions where the hematopoietic system is stressed or in transplantation experiments. For example, <italic>Hoxb4</italic><sup>&#x02212;/&#x02212;</sup> mice develop normally and present with only subtle differences in spleen and BM cellularity &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b47">47</xref>&#x0005d;. However, the proliferative response of HSC in vitro and in vivo is decreased, consistent with the observation that overexpression of <italic>Hoxb4</italic> supports expansion of competitive repopulating units and SCID-repopulating cells &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b04">4</xref>,<xref ref-type="bibr" rid="pbio-0030254-b05">5</xref>&#x0005d;.</p></sec></sec><sec id="s2c"><title>Characterization of <italic>Sprouty</italic> Family Members in Zebrafish Hematopoiesis</title><p>To further verify the hematopoietic role of genes identified by gene array, we performed a more extensive evaluation of the zebrafish targeted with an MO against <italic>spry4</italic> (spry4 morphant or spry4<sup>MO</sup>). Although human <italic>SPRY1</italic> was differentially expressed, an MO against zebrafish <italic>spry4</italic> was used, as it is expressed in the region of the lateral plate mesoderm, the first site of zebrafish hematopoiesis &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b48">48</xref>&#x0005d;, and it was the full-length zebrafish <italic>Sprouty</italic> gene with the greatest protein homology to human <italic>SPRY1</italic>. Recently the partial sequence of a potential zebrafish <italic>spry1</italic> ortholog was predicted by Ensembl's gene prediction software based on genomic sequence information. However, the single exon that was predicted does not contain an ATG start codon, or a conserved splice donor or acceptor site, and the putative zebrafish <italic>spry1</italic> sequence only partially covers the human <italic>SPRY1</italic> gene. Moreover, the genomic location of Ensembl's putative zebrafish <italic>spry1</italic> is currently not known, and therefore it is not possible to use syntenic relationships to determine the most likely zebrafish ortholog for human <italic>SPRY1</italic>. At present, there is not sufficient sequence data available to design gain- or loss-of-function experiments for the putative zebrafish <italic>spry1</italic>, thus precluding an analysis of hematopoietic function in the zebrafish model. Therefore, <italic>spry4</italic> is currently the best full-length, MO-targetable candidate ortholog for human SPRY1, and based on our results, at the very least zebrafish <italic>spry4</italic> and <italic>SPRY1</italic> share a conserved function in hematopoiesis.</p><p>To confirm the specificity of MO targeting in the spry4<sup>MO</sup>, a second <italic>spry4</italic> MO of independent sequence and a four-base mismatched <italic>spry4</italic> MO were injected into zebrafish embryos. Injection of the independent <italic>spry4</italic> MOs induced a hematopoietic phenotype in more than 65&#x00025; of injected embryos, while the four-base mismatched MO did not induce any phenotypic changes (<xref ref-type="fig" rid="pbio-0030254-g004">Figure 4</xref>). Q-RT-PCR for <italic>hbae1</italic> and <italic>lcp1</italic> transcripts also did not show changes in expression in four-base mismatched MO embryos. Furthermore, the two independent <italic>spry4</italic> MOs acted synergistically when coinjected (<xref ref-type="fig" rid="pbio-0030254-g004">Figure 4</xref>). In addition to the blood phenotype, a slight facial outgrowth was seen at a low frequency. Also, a weak dorsalization phenotype was seen at 2-fold higher MO doses based on a decreased somite size.</p><p>To rule out the possibility that the hematopoietic defect observed in the spry4<sup>MO</sup> was secondary to a vascular defect, we injected <italic>spry4</italic> MO into <italic>fli1:</italic>EGFP Tg zebrafish. While the resulting embryos exhibited minor defects in cardinal vein remodeling and morphogenesis of intersegmental vessels in the posterior tail, there were no major defects in vascular development (<xref ref-type="fig" rid="pbio-0030254-g004">Figure 4</xref>). The integrity of the vascular network in spry4<sup>MO</sup> fish was further demonstrated by the unimpeded circulation of the remaining DsRed<sup>+</sup> blood cells in <italic>gata1:</italic>DsRed Tg spry4<sup>MO</sup> (data not shown).</p><p>Thisse et al. &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b35">35</xref>&#x0005d; have shown that overexpression of zebrafish <italic>spry4</italic> mRNA leads to an expansion of the posterior intermediate cell mass (ICM) &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b48">48</xref>&#x0005d;. We overexpressed human <italic>SPRY1</italic> in <italic>gata1:</italic>DsRed Tg zebrafish embryos, and observed a similar dose-dependent expansion of DsRed<sup>+</sup> blood cells in the posterior ICM (<xref ref-type="fig" rid="pbio-0030254-g004">Figure 4</xref>). Q-RT-PCR analysis of embryos overexpressing <italic>SPRY1</italic> revealed a 1.7- and 1.4-fold increase <italic>hbae1</italic> and <italic>lcp1</italic> mRNA levels, respectively, confirming the observed expansion of blood cells in the ICM. Coinjection of human <italic>SPRY1</italic> cDNA with <italic>spry4</italic> MOs ameliorated the spry4<sup>MO</sup> phenotype, yet another confirmation of the specificity of MO targeting (<xref ref-type="fig" rid="pbio-0030254-g004">Figure 4</xref>). The similar hematopoietic phenotypes observed following the overexpression of either human <italic>SPRY1</italic> or zebrafish <italic>spry4</italic> indicate that these genes encode proteins with a similar functional potential in blood development. In addition to the blood phenotype, the overexpression often caused a reduction and/or curve in the posterior tail (<xref ref-type="fig" rid="pbio-0030254-g004">Figure 4</xref>) not seen in the overexpression of zebrafish <italic>spry4</italic> &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b48">48</xref>&#x0005d;.</p><p>Characterization of hematopoietic gene expression in the spry4<sup>MO</sup> by whole-mount in situ hybridization revealed a reduction in <italic>scl</italic> expression at four somites (8/15), and virtually no <italic>scl</italic> (12/20) or <italic>gata1</italic> (18/25) expression at 20 somites (<xref ref-type="fig" rid="pbio-0030254-g005">Figure 5</xref>), consistent with a defect in mesodermal commitment to HSCs and/or HSC proliferation and differentiation. The few hematopoietic cells that are present in the morphant are hemoglobinized based on <italic>o</italic>-dianisidine staining (data not shown). To determine whether the hematopoietic defects observed in spry4<sup>MO</sup> were the result of a defect in mesoderm specification during development, we performed whole-mount in situ hybridization for the vasculature-specific <italic>flk1</italic> and muscle-specific <italic>myod</italic> transcripts. At 10 h postfertilization (hpf) there was a slight defect in <italic>myod</italic> expression (5/10), while <italic>myod</italic> expression at 26 hpf was comparable to wild type (21/21) (<xref ref-type="fig" rid="pbio-0030254-g005">Figure 5</xref>). This suggests that there were no major defects in mesodermal commitment in the spry4 morphants. Considering the nearly absent expression of the early hemangioblast and HSC cell marker <italic>scl</italic>, these results may suggest that the defect induced in the spry4<sup>MO</sup> occurs prior to HSC specification. However, the normal expression pattern of other mesodermal genes, such as <italic>flk1</italic> and <italic>myod</italic> at 26 hpf in the spry4<sup>MO</sup> (<xref ref-type="fig" rid="pbio-0030254-g005">Figure 5</xref>), indicate that the hematopoietic phenotype is not merely a consequence of defective specification of mesoderm. Finally, the hematopoietic gene <italic>cmyb</italic>, a presumed marker of definitive HSC in zebrafish &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b49">49</xref>&#x0005d;, was absent at 38 hpf (10/12) (data not shown), suggesting that the spry4<sup>MO</sup> embryos are devoid of definitive HSC.</p><p>In vertebrates, <italic>Sprouty</italic> family members act as antagonists for fibroblast growth factor (FGF), vascular endothelial growth factor, and epidermal growth factor signaling, and they may be involved in feedback regulation, as <italic>Sprouty</italic> gene expression is induced by activation of these signaling pathways &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b50">50</xref>&#x0005d;. <italic>Sprouty</italic> genes antagonize receptor tyrosine kinase signaling at the level of the Ras/Raf/mitogen-activated protein kinase pathway; however, they also can serve as positive regulators of these pathways in some cell types &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b50">50</xref>&#x0005d;. Therefore, our current hypothesis is that <italic>SPRY1</italic> may affect HSC by modulating FGF-mediated, perhaps in combination with other receptor tyrosine kinase-mediated, signaling. In fact, three of the 14 genes that induce a hematopoietic defect in the zebrafish screen, <italic>SPRY1</italic>,<italic>MAFB</italic> and <italic>SPARC</italic>, are all involved in FGF signaling &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b50">50</xref>&#x02013;<xref ref-type="bibr" rid="pbio-0030254-b52">52</xref>&#x0005d;, thus suggesting a role for FGF in hematopoiesis. Studies are ongoing to confirm a role of <italic>SPRY1</italic> in mammalian hematopoiesis, by testing the effect of overexpression of <italic>SPRY1</italic> on the repopulating ability of human and murine HSCs. Similar definitive studies in zebrafish and subsequent confirmation in mammalian HSC models are underway for genes that were functionally validated in our zebrafish screen. We believe that the sequential genetic screen in zebrafish followed by confirmation in mammalian models as described here will establish a hematopoietic function for genes identified by gene array analysis in a high-throughput and efficient manner.</p></sec></sec><sec id="s3"><title>Materials and Methods</title><sec id="s3a"><title>Isolation of Rho<sup>lo</sup> and Rho<sup>hi</sup> cell populations from UCB and BM</title><p>Human UCB from full-term delivered infants and BM from healthy donors were obtained after informed consent in accordance with guidelines approved by the University of Minnesota Committee on the Use of Human Subjects in Research. Each biologically distinct replicate was comprised of one to four donors for UCB and individual donors for BM samples. CD34<sup>+</sup>CD38<sup>&#x02212;</sup>CD33<sup>&#x02212;</sup>Rho<sup>lo</sup>c-kit<sup>+</sup> and CD34<sup>+</sup>CD38<sup>&#x02212;</sup>CD33<sup>&#x02212;</sup>Rho<sup>hi</sup> fractions were selected by sequential Ficoll-Hypaque separation, MACS column depletion, and fluorescence-activated cell sorting as previously described &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b17">17</xref>&#x0005d;. Postsort analysis demonstrated that sorted populations contained fewer than 1&#x00025;&#x02013;2&#x00025; contaminating cells from the opposing population (see <xref ref-type="fig" rid="pbio-0030254-g001">Figure 1</xref>).</p></sec><sec id="s3b"><title>Determination of ML&#x02013;IC frequencies</title><p>ML&#x02013;IC frequencies for UCB samples (<italic>n</italic> = 3) were determined as previously described &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b17">17</xref>&#x0005d;. An ML&#x02013;IC was defined as a single cell that gave rise to at least one LTC&#x02013;IC and one NK&#x02013;IC. Results are presented as ML&#x02013;IC frequency &#x000b1; standard deviation of the mean.</p></sec><sec id="s3c"><title>Processing of RNA samples and oligonucleotide microarray analysis</title><p>Total cellular RNA was isolated from UCB (<italic>n</italic> = 5) and BM (<italic>n</italic> = 4) Rho<sup>lo</sup> and Rho<sup>hi</sup> cells using the PicoPure RNA Isolation Kit (Arcturus, Mountain View, California, United States) per the manufacturer's instructions. Seven to 10,000 Rho<sup>lo</sup> and Rho<sup>hi</sup> cells were sorted directly into 100 &#x003bc;l extraction buffer (XB) provided with the PicoPure RNA Isolation Kit prior to RNA isolation. Labeled cRNA was generated by one round of IVT-based, linear amplification using the RiboAmp OA RNA Amplification Kit (Arcturus) followed by labeling with the Enzo Bioarray HighYield RNA Transcript Labeling Kit (Enzo Life Sciences, Farmingdale, New York, United States) according to manufacturer's instructions. Samples were hybridized to Affymetrix HG-U133 A and B chips (Affymetrix Inc., Santa Clara, California, United States) were washed, and scanned at the University of Minnesota Affymetrix Microarray Core Facility as described in the <italic>Affymetrix GeneChip Expression Analysis Technical Manual.</italic></p></sec><sec id="s3d"><title>Oligonucleotide microarray data analysis</title><p>Affymetrix HG-U133 GeneChips were processed using GeneData Refiner software (GeneData, San Francisco, California, United States) to assess overall quality. Feature intensities for each chip were condensed into a single intensity value per gene using the Affymetrix Statistical Algorithm (MAS 5.0) with &#x003c4; = 0.015, &#x003b1;1 = 0.04, &#x003b1;2 = 0.06, and a scaling factor of 500. Expression data was analyzed using GeneData's Expressionist and Microsoft Excel (Microsoft, Redmond, Washington, United States). Differential gene expression for comparison of Rho<sup>lo</sup> versus Rho<sup>hi</sup> cells was defined by using a paired Student's <italic>t</italic>-test with a threshold of <italic>p</italic>&#x0003c; 0.05, and a paired fold change was used to rank gene lists. Differentially expressed genes were classified according to their respective gene pathways and gene ontologies when available by using the Web-based Affymetrix NetAffx analysis tool (<ext-link ext-link-type="uri" xlink:href="http://www.affymetrix.com">http://www.affymetrix.com</ext-link>) and the National Institutes of Allergy and Infectious Disease Database for Annotation, Visualization and Integrated Discovery analysis tool (DAVID) (<ext-link ext-link-type="uri" xlink:href="http://apps1.niaid.nih.gov/david">http://apps1.niaid.nih.gov/david</ext-link>).</p></sec><sec id="s3e"><title>Microarray Q-RT-PCR confirmation</title><p>Labeled cRNA was reverse transcribed to generate cDNA using SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, California, United States) according to manufacturer's instructions. Q-RT-PCR was performed using the ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, California, United States). Briefly, 3 ng of cDNA was amplified by 40 cycles of a two-step PCR reaction (95 &#x000b0;C for 15 s denaturation and 60 &#x000b0;C for 1 min. annealing/elongation) containing 100 nM gene-specific primers (<xref ref-type="supplementary-material" rid="st008">Table S8</xref>) and the SYBR Green PCR Master Mix (Applied Biosystems). Gene expression was normalized using human <italic>ACTB</italic> (also <italic>&#x003b2;-actin</italic>) expression levels. Results are presented as percent expression relative to uninjected clutchmate control embryos &#x000b1; standard deviation of the mean.</p></sec><sec id="s3f"><title>High-throughput loss-of-function genetic screen in zebrafish</title><p>The likely zebrafish orthologs of differentially expressed human genes were identified using Ensembl's gene homology prediction program (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org">http://www.ensembl.org</ext-link>, build Zv3) in combination with comparison of the human protein sequence to the Institute for Genomic Research zebrafish EST database (<ext-link ext-link-type="uri" xlink:href="http://www.tigr.org">http://www.tigr.org</ext-link>, release 13&#x02013;15). The criteria for a likely ortholog was &#x02265; 40&#x00025; amino acid identity over the entire length of the protein or &#x02265; 50&#x00025; if the fish protein sequence was only partial. MO (Gene Tools, Philomath, Oregon, United States) sequences were designed complimentary to the region of translational initiation of the zebrafish orthologs in order to inhibit protein translation (<xref ref-type="supplementary-material" rid="st006">Table S6</xref>) and injected into one- to two-cell zebrafish embryos as previously described &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b36">36</xref>&#x0005d;. MOs were injected at 1.5, 3, 4.5, and 6 ng into 50&#x02013;70 embryos derived from mating Tg zebrafish containing a fluorescent DsRed reporter cassette driven by the <italic>gata1</italic> promoter (<italic>gata1:</italic>DsRed Tg) or a fluorescent EGFP reporter cassette driven by the <italic>fli1</italic> promoter (<italic>fli1:</italic>EGFP Tg). MO-targeted (morphant) zebrafish were evaluated for defects in hematopoietic and vascular development compared to uninjected controls from the same embryo clutch at 30 and 48 hpf, using fluorescence microscopy for visualization of DsRed<sup>+</sup> blood cells and EGFP<sup>+</sup> vasculature.</p></sec><sec id="s3g"><title>Whole zebrafish Q-RT-PCR confirmation</title><p>Total RNA was isolated from five MO-injected zebrafish embryos at 48 hpf with hematopoietic defects, determined based on <italic>gata1:</italic>DsRed<sup>+</sup> hematopoietic cell production, or five uninjected clutchmate controls using the RNeasy Mini Kit (Qiagen, Valencia, California, United States) according to the manufacturer's instructions. Total RNA was incubated with DNaseI (Invitrogen) to digest contaminating genomic DNA, and reverse transcribed to generate cDNA using SuperScript II Reverse Transcriptase (Invitrogen) according to the manufacturer's protocol. Q-RT-PCR was performed using the ABI Prism 7000 Sequence Detection System (Applied Biosystems). Briefly, 1/20 of the total cDNA from five zebrafish embryos was amplified by 40 cycles of a two-step PCR reaction (95 &#x000b0;C for 15 s denaturation and 60 &#x000b0;C for 1 min. annealing/elongation) containing 100 nM gene-specific primers (<xref ref-type="supplementary-material" rid="st008">Table S8</xref>) and the SYBR Green PCR Master Mix (Applied Biosystems). Gene expression was normalized using a zebrafish <italic>gapd</italic> expression level. Results are presented as percentage expression relative to uninjected clutchmate control embryos &#x000b1; standard deviation of the mean.</p></sec><sec id="s3h"><title>Whole-mount in situ hybridization</title><p>The <italic>scl, myod, flk1</italic>, <italic>gata1</italic>, and <italic>cmyb</italic> riboprobes were generated and whole-mount in situ hybridization of zebrafish embryos was conducted as previously described &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b41">41</xref>&#x0005d;.</p></sec><sec id="s3i"><title>Overexpression of human and zebrafish <italic>Sprouty</italic> gene family members</title><p>The XhoI and KpnI fragment of the <italic>SPRY1</italic> open reading frame (ORF) (Open Biosystems, Huntsville, Alabama, United States) was cloned into pENTR1A (Invitrogen) and subsequently transferred into a modified pFRM2.1 zebrafish expression vector using the Gateway cloning system (Invitrogen) to create the pFRM2.1&#x02013;SPRY1 vector. pFRM2.1&#x02013;SPRY1 was coinjected with pFRM2.1&#x02013;EGFP at a 5:1 ratio into the yolk/cell interface of one-cell <italic>gata1:</italic>DsRed Tg zebrafish embryos as described for MO injections. Defects in hematopoietic development of EGFP<sup>+</sup> embryos were analyzed by comparison to embryos from the same clutch injected with pFRM2.1&#x02013;EGFP alone, using fluorescence microscopy to visualize DsRed<sup>+</sup> blood cells.</p></sec></sec><sec sec-type="supplementary-material" id="s4"><title>Supporting Information</title><supplementary-material content-type="local-data" id="sg001"><label>Figure S1</label><caption><title>Frequency of ML&#x02013;IC in UCB Rho<sup>lo</sup> and Rho<sup>hi</sup> Cell Populations</title><p>ML&#x02013;ICs are highly enriched in Rho<sup>lo</sup> (white bar) compared to Rho<sup>hi</sup> (black bar) cells from UCB (<italic>n</italic> = 3, &#x0002a;<italic>p</italic> &#x0003c; 0.05).</p><p>(3.6 MB TIF).</p></caption><media xlink:href="pbio.0030254.sg001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sg002"><label>Figure S2</label><caption><title>Confirmation of Differential Gene Expression Using Q-RT-PCR</title><p>The Rho<sup>lo</sup> to Rho<sup>hi</sup> fold change for <italic>DLK1</italic>, <italic>ABCB1</italic>, <italic>BMP6</italic>, <italic>HELLS</italic>, <italic>CDC25A</italic>, <italic>MAFB</italic>, and <italic>S100A8</italic> was determined using Affymetrix GeneChip analysis (gray bars) and Q-RT-PCR (black bars) to confirm the fidelity of the microarray results for (A) adult BM (<italic>n</italic> &#x02265; 2) and (B) UCB (<italic>n</italic> &#x02265; 3).</p><p>(7.2 MB TIF).</p></caption><media xlink:href="pbio.0030254.sg002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sg003"><label>Figure S3</label><caption><title>Gene Ontology Classifications of Conserved Differentially Expressed Genes</title><p>Percentages of Gene Ontology classifications of the genes differentially expressed between Rho<sup>lo</sup> and Rho<sup>hi</sup> cells from both UCB and adult BM (<italic>p</italic> &#x0003c; 0.05 and fold change &#x0003e; 1.5 in either UCB or BM).</p><p>(2.7 MB TIF).</p></caption><media xlink:href="pbio.0030254.sg003.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="st001"><label>Table S1</label><caption><title>Probe Sets Differentially Expressed between UCB-Derived Rho<sup>lo</sup> and Rho<sup>hi</sup> Cells (<italic>p</italic> &#x0003c; 0.05)</title><p>(437 KB XLS).</p></caption><media xlink:href="pbio.0030254.st001.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="st002"><label>Table S2</label><caption><title>Probe Sets Differentially Expressed between Adult BM-Derived Rho<sup>lo</sup> and Rho<sup>hi</sup> Cells (<italic>p</italic> &#x0003c; 0.05)</title><p>(738 KB XLS).</p></caption><media xlink:href="pbio.0030254.st002.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="st003"><label>Table S3</label><caption><title>Conserved Probe Sets Differentially Expressed between Rho<sup>lo</sup> and Rho<sup>hi</sup> Cells from Both UCB and Adult BM (<italic>p</italic> &#x0003c; 0.05 and FC &#x0003e; 1.5 in Either UCB or BM)</title><p>(75 KB XLS).</p></caption><media xlink:href="pbio.0030254.st003.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="st004"><label>Table S4</label><caption><title>Fold Changes, <italic>p</italic>-Values, and Average Expression Levels for Genes with Well-Established Roles in HSC Proliferation and Differentiation</title><p>(17 KB XLS).</p></caption><media xlink:href="pbio.0030254.st004.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="st005"><label>Table S5</label><caption><title>Comparison of Conserved Rho<sup>lo</sup>-Enriched Genes with Ramalho-Santos et al. &#x0005b;<xref ref-type="bibr" rid="pbio-0030254-b13">13</xref>&#x0005d; Dataset</title><p>(22 KB XLS).</p></caption><media xlink:href="pbio.0030254.st005.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="st006"><label>Table S6</label><caption><title>Morpholino Sequences for Targeted Genes</title><p>(20 KB XLS).</p></caption><media xlink:href="pbio.0030254.st006.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="st007"><label>Table S7</label><caption><title>Complete Phenotypic Descriptions for the 14 Zebrafish Morphants with Confirmed Blood Defects</title><p>(19 KB XLS).</p></caption><media xlink:href="pbio.0030254.st007.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="st008"><label>Table S8</label><caption><title>Q-RT-PCR Primer Sequences</title><p>(16 KB XLS).</p></caption><media xlink:href="pbio.0030254.st008.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><sec id="s4a"><title>Accession Numbers</title><p>The National Center for Biotechnology Information (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</ext-link>) Entrez Gene accession numbers for the following genes are: ABCB1 (5243), ARMCX2 (9823), BMP4 (652), C12orf2 (11228), CCR7 (1236), Ccr7 (12775), CDKN1A (1026), chd (30161), cmyb (30519), CRYGD (1421), EVI1 (2122), EZH2 (2146), FLJ14917 (84947), flk1 (also known as kdr) (58106), FOXM1 (2305), gata1 (30481), GATA2 (2624), gata2 (30480), hbae1 (30597), HDHD2 (84064), HELLS (3070), HLF (3131), HMGA2 (8091), Hoxb4 (15412), HOXB4 (3214), HSPC039 (51124), IRAK3 (11213), Irak3 (73914), KIAA1102 (22998), KLF5 (688), lcp1 (30583), LEF1 (51176), LMO2 (4005), lmo2 (30332), MAFB (9935), MGC15875 (85007), MRPS6 (64968), myod (30513), NOTCH2 (4853), PIM1 (5292), PRKCH (5583), Prkch (18755), RBPMS (11030), scl (also known as tal1) (30766), SHH (6469), SLC40A1 (30061), SLCO3A1 (28232), SNX5 (27131), SPARC (6678), Sparc (20692), spry4 (114437), SPRY1 (10252), SSBP2 (23635), SUZ12 (23512), ZFHX1B (9839), ZNF165 (7718), and ZNF331 (55422). </p><p>The microarray data in this manuscript have been deposited in the GEO database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link>, and have been assigned the accession number GSE2666.</p></sec></sec></body><back><ack><p>We thank Brent Bill, Aubrey Nielsen, and Shridhar Sivasubbu for zebrafish injections, Greg Veltri and Joel Sederstrom for cell sorting at the University of Minnesota Flow Cytometry Facility, Dr. Leonard Zon for the <italic>gata1:</italic>DsRed Tg zebrafish line, and Drs. Stephanie Salesse and David Largaespada for critical review of the manuscript. This research was supported by Medical Scientist Training Program (GM008244) and National Cancer Institute (NCI) (CA009138) training grants to CEE, a MinnCResT training fellowship to MAP sponsored by the National Institute of Dental and Craniofacial Research (DE07288), NCI Program Project Grant (CA065493) to CMV, and National Institute of General Medical Sciences R01 (GM63904) to SCE.</p><p><bold>Competing interests.</bold> University of Minnesota and Stephen C. Ekker are cofounders and shareholders of a small biotechnology company called Discovery Genomics Inc. that has the exclusive license for the commercial use of morpholinos in zebrafish. Dr. Ekker is a consultant to this company.</p></ack><fn-group><fn id="n1" fn-type="con"><p><bold>Author contributions.</bold> CEE, EMM, SCE, and CMV conceived and designed the experiments. CEE, EMM, CMF, and TFW performed the experiments. CEE, EMM, CMF, TFW, SMG, SCE, and CMV analyzed the data. MAP and SMG contributed reagents/materials/analysis tools. CEE, EMM, SCE, and CMV wrote the paper.</p></fn></fn-group><ref-list><title>References</title><ref id="pbio-0030254-b01"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>SJ</given-names></name><name><surname>Uchida</surname><given-names>N</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name></person-group><article-title>The biology of hematopoietic stem cells</article-title><source>Annu Rev Cell Dev Biol</source><year>1995</year><volume>11</volume><fpage>35</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">8689561</pub-id></citation></ref><ref id="pbio-0030254-b02"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krause</surname><given-names>DS</given-names></name></person-group><article-title>Regulation of hematopoietic stem cell fate</article-title><source>Oncogene</source><year>2002</year><volume>21</volume><fpage>3262</fpage><lpage>3269</lpage><pub-id pub-id-type="pmid">12032767</pub-id></citation></ref><ref id="pbio-0030254-b03"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sauvageau</surname><given-names>G</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Eaves</surname><given-names>CJ</given-names></name><name><surname>Lawrence</surname><given-names>HJ</given-names></name><name><surname>Largman</surname><given-names>C</given-names></name></person-group><article-title>Overexpression of <italic>HOXB4</italic> in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo</article-title><source>Genes Dev</source><year>1995</year><volume>9</volume><fpage>1753</fpage><lpage>1765</lpage><pub-id pub-id-type="pmid">7622039</pub-id></citation></ref><ref id="pbio-0030254-b04"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antonchuk</surname><given-names>J</given-names></name><name><surname>Sauvageau</surname><given-names>G</given-names></name><name><surname>Humphries</surname><given-names>RK</given-names></name></person-group><article-title><italic>HOXB4</italic> overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation</article-title><source>Exp Hematol</source><year>2001</year><volume>29</volume><fpage>1125</fpage><lpage>1134</lpage><pub-id pub-id-type="pmid">11532354</pub-id></citation></ref><ref id="pbio-0030254-b05"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buske</surname><given-names>C</given-names></name><name><surname>Feuring-Buske</surname><given-names>M</given-names></name><name><surname>Abramovich</surname><given-names>C</given-names></name><name><surname>Spiekermann</surname><given-names>K</given-names></name><name><surname>Eaves</surname><given-names>CJ</given-names></name></person-group><article-title>Deregulated expression of <italic>HOXB4</italic> enhances the primitive growth activity of human hematopoietic cells</article-title><source>Blood</source><year>2002</year><volume>100</volume><fpage>862</fpage><lpage>868</lpage><pub-id pub-id-type="pmid">12130496</pub-id></citation></ref><ref id="pbio-0030254-b06"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Varnum-Finney</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Brashem-Stein</surname><given-names>C</given-names></name><name><surname>Nourigat</surname><given-names>C</given-names></name><name><surname>Flowers</surname><given-names>D</given-names></name></person-group><article-title>Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive <italic>Notch1</italic> signaling</article-title><source>Nat Med</source><year>2000</year><volume>6</volume><fpage>1278</fpage><lpage>1281</lpage><pub-id pub-id-type="pmid">11062542</pub-id></citation></ref><ref id="pbio-0030254-b07"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reya</surname><given-names>T</given-names></name><name><surname>Duncan</surname><given-names>AW</given-names></name><name><surname>Ailles</surname><given-names>L</given-names></name><name><surname>Domen</surname><given-names>J</given-names></name><name><surname>Scherer</surname><given-names>DC</given-names></name></person-group><article-title>A role for Wnt signalling in self-renewal of haematopoietic stem cells</article-title><source>Nature</source><year>2003</year><volume>423</volume><fpage>409</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">12717450</pub-id></citation></ref><ref id="pbio-0030254-b08"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murdoch</surname><given-names>B</given-names></name><name><surname>Chadwick</surname><given-names>K</given-names></name><name><surname>Martin</surname><given-names>M</given-names></name><name><surname>Shojaei</surname><given-names>F</given-names></name><name><surname>Shah</surname><given-names>KV</given-names></name></person-group><article-title>Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>3422</fpage><lpage>3427</lpage><pub-id pub-id-type="pmid">12626754</pub-id></citation></ref><ref id="pbio-0030254-b09"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhardwaj</surname><given-names>G</given-names></name><name><surname>Murdoch</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Baker</surname><given-names>DP</given-names></name><name><surname>Williams</surname><given-names>KP</given-names></name></person-group><article-title>Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation</article-title><source>Nat Immunol</source><year>2001</year><volume>2</volume><fpage>172</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">11175816</pub-id></citation></ref><ref id="pbio-0030254-b10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Terskikh</surname><given-names>AV</given-names></name><name><surname>Miyamoto</surname><given-names>T</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name><name><surname>Diatchenko</surname><given-names>L</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name></person-group><article-title>Gene expression analysis of purified hematopoietic stem cells and committed progenitors</article-title><source>Blood</source><year>2003</year><volume>102</volume><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">12623852</pub-id></citation></ref><ref id="pbio-0030254-b11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>IK</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Laerum</surname><given-names>OD</given-names></name><name><surname>Tian</surname><given-names>Q</given-names></name></person-group><article-title>Differential gene expression profiling of adult murine hematopoietic stem cells</article-title><source>Blood</source><year>2002</year><volume>99</volume><fpage>488</fpage><lpage>498</lpage><pub-id pub-id-type="pmid">11781229</pub-id></citation></ref><ref id="pbio-0030254-b12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ivanova</surname><given-names>NB</given-names></name><name><surname>Dimos</surname><given-names>JT</given-names></name><name><surname>Schaniel</surname><given-names>C</given-names></name><name><surname>Hackney</surname><given-names>JA</given-names></name><name><surname>Moore</surname><given-names>KA</given-names></name></person-group><article-title>A stem cell molecular signature</article-title><source>Science</source><year>2002</year><volume>298</volume><fpage>601</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">12228721</pub-id></citation></ref><ref id="pbio-0030254-b13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramalho-Santos</surname><given-names>M</given-names></name><name><surname>Yoon</surname><given-names>S</given-names></name><name><surname>Matsuzaki</surname><given-names>Y</given-names></name><name><surname>Mulligan</surname><given-names>RC</given-names></name><name><surname>Melton</surname><given-names>DA</given-names></name></person-group><article-title>&#x0201c;Stemness&#x0201d;: Transcriptional profiling of embryonic and adult stem cells</article-title><source>Science</source><year>2002</year><volume>298</volume><fpage>597</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">12228720</pub-id></citation></ref><ref id="pbio-0030254-b14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fortunel</surname><given-names>NO</given-names></name><name><surname>Otu</surname><given-names>HH</given-names></name><name><surname>Ng</surname><given-names>HH</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Mu</surname><given-names>X</given-names></name></person-group><article-title>Comment on &#x0201c;&#x02018;Stemness': Transcriptional profiling of embryonic and adult stem cells&#x0201d; and &#x0201c;a stem cell molecular signature.&#x0201d;</article-title><source>Science</source><year>2003</year><volume>302</volume><fpage>393</fpage></citation></ref><ref id="pbio-0030254-b15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhatia</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>JC</given-names></name><name><surname>Kapp</surname><given-names>U</given-names></name><name><surname>Bonnet</surname><given-names>D</given-names></name><name><surname>Dick</surname><given-names>JE</given-names></name></person-group><article-title>Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice</article-title><source>Proc Natl Acad Sci U S A</source><year>1997</year><volume>94</volume><fpage>5320</fpage><lpage>5325</lpage><pub-id pub-id-type="pmid">9144235</pub-id></citation></ref><ref id="pbio-0030254-b16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shojaei</surname><given-names>F</given-names></name><name><surname>Gallacher</surname><given-names>L</given-names></name><name><surname>Bhatia</surname><given-names>M</given-names></name></person-group><article-title>Differential gene expression of human stem progenitor cells derived from early stages of in utero human hematopoiesis</article-title><source>Blood</source><year>2004</year><volume>103</volume><fpage>2530</fpage><lpage>2540</lpage><pub-id pub-id-type="pmid">14656878</pub-id></citation></ref><ref id="pbio-0030254-b17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Verfaillie</surname><given-names>CM</given-names></name></person-group><article-title>Myeloid&#x02013;lymphoid initiating cells (ML&#x02013;IC) are highly enriched in the rhodamine-c-kit(+)CD33(&#x02212;)CD38(&#x02212;) fraction of umbilical cord CD34(+) cells</article-title><source>Exp Hematol</source><year>2002</year><volume>30</volume><fpage>582</fpage><lpage>589</lpage><pub-id pub-id-type="pmid">12063025</pub-id></citation></ref><ref id="pbio-0030254-b18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>T</given-names></name><name><surname>Rodrigues</surname><given-names>N</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Dombkowski</surname><given-names>D</given-names></name></person-group><article-title>Hematopoietic stem cell quiescence maintained by p21cip1/waf1</article-title><source>Science</source><year>2000</year><volume>287</volume><fpage>1804</fpage><lpage>1808</lpage><pub-id pub-id-type="pmid">10710306</pub-id></citation></ref><ref id="pbio-0030254-b19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seidel</surname><given-names>MG</given-names></name><name><surname>Look</surname><given-names>AT</given-names></name></person-group><article-title>E2A-HLF usurps control of evolutionarily conserved survival pathways</article-title><source>Oncogene</source><year>2001</year><volume>20</volume><fpage>5718</fpage><lpage>5725</lpage><pub-id pub-id-type="pmid">11607821</pub-id></citation></ref><ref id="pbio-0030254-b20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buonamici</surname><given-names>S</given-names></name><name><surname>Chakraborty</surname><given-names>S</given-names></name><name><surname>Senyuk</surname><given-names>V</given-names></name><name><surname>Nucifora</surname><given-names>G</given-names></name></person-group><article-title>The role of <italic>EVI1</italic> in normal and leukemic cells</article-title><source>Blood Cells Mol Dis</source><year>2003</year><volume>31</volume><fpage>206</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">12972028</pub-id></citation></ref><ref id="pbio-0030254-b21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>AJ</given-names></name><name><surname>Colledge</surname><given-names>WH</given-names></name><name><surname>Carlton</surname><given-names>MB</given-names></name><name><surname>Evans</surname><given-names>MJ</given-names></name><name><surname>Smith</surname><given-names>AJ</given-names></name></person-group><article-title>The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development</article-title><source>Cell</source><year>1994</year><volume>78</volume><fpage>45</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">8033210</pub-id></citation></ref><ref id="pbio-0030254-b22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Lim</surname><given-names>KC</given-names></name><name><surname>Onodera</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Ohta</surname><given-names>J</given-names></name></person-group><article-title>Rescue of the embryonic lethal hematopoietic defect reveals a critical role for <italic>GATA</italic><italic>-2</italic> in urogenital development</article-title><source>EMBO J</source><year>1998</year><volume>17</volume><fpage>6689</fpage><lpage>6700</lpage><pub-id pub-id-type="pmid">9822612</pub-id></citation></ref><ref id="pbio-0030254-b23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Travis</surname><given-names>A</given-names></name><name><surname>Amsterdam</surname><given-names>A</given-names></name><name><surname>Belanger</surname><given-names>C</given-names></name><name><surname>Grosschedl</surname><given-names>R</given-names></name></person-group><article-title>LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function &#x0005b;corrected&#x0005d;</article-title><source>Genes Dev</source><year>1991</year><volume>5</volume><fpage>880</fpage><lpage>894</lpage><pub-id pub-id-type="pmid">1827423</pub-id></citation></ref><ref id="pbio-0030254-b24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bigas</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>DI</given-names></name><name><surname>Milner</surname><given-names>LA</given-names></name></person-group><article-title><italic>Notch1</italic> and <italic>Notch2</italic> inhibit myeloid differentiation in response to different cytokines</article-title><source>Mol Cell Biol</source><year>1998</year><volume>18</volume><fpage>2324</fpage><lpage>2333</lpage><pub-id pub-id-type="pmid">9528802</pub-id></citation></ref><ref id="pbio-0030254-b25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hashizume</surname><given-names>H</given-names></name><name><surname>Hamalainen</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Sucharczuk</surname><given-names>A</given-names></name><name><surname>Lahesmaa</surname><given-names>R</given-names></name></person-group><article-title>Downregulation of <italic>mafB</italic> expression in T-helper cells during early differentiation in vitro</article-title><source>Scand J Immunol</source><year>2003</year><volume>57</volume><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">12542795</pub-id></citation></ref><ref id="pbio-0030254-b26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geiman</surname><given-names>TM</given-names></name><name><surname>Muegge</surname><given-names>K</given-names></name></person-group><article-title>Lsh, an SNF2/helicase family member, is required for proliferation of mature T lymphocytes</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><volume>97</volume><fpage>4772</fpage><lpage>4777</lpage><pub-id pub-id-type="pmid">10781083</pub-id></citation></ref><ref id="pbio-0030254-b27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Birve</surname><given-names>A</given-names></name><name><surname>Sengupta</surname><given-names>AK</given-names></name><name><surname>Beuchle</surname><given-names>D</given-names></name><name><surname>Larsson</surname><given-names>J</given-names></name><name><surname>Kennison</surname><given-names>JA</given-names></name></person-group><article-title><italic>Su(z)12</italic> a novel <italic>Drosophila Polycomb</italic> group gene that is conserved in vertebrates and plants</article-title><source>Development</source><year>2001</year><volume>128</volume><fpage>3371</fpage><lpage>3379</lpage><pub-id pub-id-type="pmid">11546753</pub-id></citation></ref><ref id="pbio-0030254-b28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruzinova</surname><given-names>MB</given-names></name><name><surname>Benezra</surname><given-names>R</given-names></name></person-group><article-title>Id proteins in development, cell cycle and cancer</article-title><source>Trends Cell Biol</source><year>2003</year><volume>13</volume><fpage>410</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">12888293</pub-id></citation></ref><ref id="pbio-0030254-b29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoyle</surname><given-names>CF</given-names></name><name><surname>Sherrington</surname><given-names>P</given-names></name><name><surname>Hayhoe</surname><given-names>FG</given-names></name></person-group><article-title>Translocation (3;6)(q21;p21) in acute myeloid leukemia with abnormal thrombopoiesis and basophilia</article-title><source>Cancer Genet Cytogenet</source><year>1988</year><volume>30</volume><fpage>261</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">3422580</pub-id></citation></ref><ref id="pbio-0030254-b30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sonoki</surname><given-names>T</given-names></name><name><surname>Harder</surname><given-names>L</given-names></name><name><surname>Horsman</surname><given-names>DE</given-names></name><name><surname>Karran</surname><given-names>L</given-names></name><name><surname>Taniguchi</surname><given-names>I</given-names></name></person-group><article-title>Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies</article-title><source>Blood</source><year>2001</year><volume>98</volume><fpage>2837</fpage><lpage>2844</lpage><pub-id pub-id-type="pmid">11675358</pub-id></citation></ref><ref id="pbio-0030254-b31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagarajan</surname><given-names>L</given-names></name><name><surname>Louie</surname><given-names>E</given-names></name><name><surname>Tsujimoto</surname><given-names>Y</given-names></name><name><surname>ar-Rushdi</surname><given-names>A</given-names></name><name><surname>Huebner</surname><given-names>K</given-names></name></person-group><article-title>Localization of the human pim oncogene (PIM) to a region of chromosome 6 involved in translocations in acute leukemias</article-title><source>Proc Natl Acad Sci U S A</source><year>1986</year><volume>83</volume><fpage>2556</fpage><lpage>2560</lpage><pub-id pub-id-type="pmid">3458216</pub-id></citation></ref><ref id="pbio-0030254-b32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ekker</surname><given-names>SC</given-names></name></person-group><article-title>Morphants: A new systematic vertebrate functional genomics approach</article-title><source>Yeast</source><year>2000</year><volume>17</volume><fpage>302</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">11119307</pub-id></citation></ref><ref id="pbio-0030254-b33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ackermann</surname><given-names>GE</given-names></name><name><surname>Paw</surname><given-names>BH</given-names></name></person-group><article-title>Zebrafish: A genetic model for vertebrate organogenesis and human disorders</article-title><source>Front Biosci</source><year>2003</year><volume>8</volume><fpage>d1227</fpage><lpage>1253</lpage><pub-id pub-id-type="pmid">12957827</pub-id></citation></ref><ref id="pbio-0030254-b34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>W</given-names></name><name><surname>Ho</surname><given-names>CY</given-names></name><name><surname>Yan</surname><given-names>YL</given-names></name><name><surname>Postlethwait</surname><given-names>J</given-names></name><name><surname>Stainier</surname><given-names>DY</given-names></name></person-group><article-title><italic>Hhex</italic> and <italic>scl</italic> function in parallel to regulate early endothelial and blood differentiation in zebrafish</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>4303</fpage><lpage>4313</lpage><pub-id pub-id-type="pmid">11003831</pub-id></citation></ref><ref id="pbio-0030254-b35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname><given-names>C</given-names></name><name><surname>Zon</surname><given-names>LI</given-names></name></person-group><article-title>Organogenesis&#x02014;Heart and blood formation from the zebrafish point of view</article-title><source>Science</source><year>2002</year><volume>295</volume><fpage>457</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">11799232</pub-id></citation></ref><ref id="pbio-0030254-b36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nasevicius</surname><given-names>A</given-names></name><name><surname>Ekker</surname><given-names>SC</given-names></name></person-group><article-title>Effective targeted gene &#x0201c;knockdown&#x0201d; in zebrafish</article-title><source>Nat Genet</source><year>2000</year><volume>26</volume><fpage>216</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">11017081</pub-id></citation></ref><ref id="pbio-0030254-b37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galloway</surname><given-names>JL</given-names></name><name><surname>Wingert</surname><given-names>RA</given-names></name><name><surname>Thisse</surname><given-names>C</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name><name><surname>Zon</surname><given-names>LI</given-names></name></person-group><article-title>Loss of <italic>gata1</italic> but not <italic>gata2</italic> converts erythropoiesis to myelopoiesis in zebrafish embryos</article-title><source>Dev Cell</source><year>2005</year><volume>8</volume><fpage>109</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">15621534</pub-id></citation></ref><ref id="pbio-0030254-b38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haffter</surname><given-names>P</given-names></name><name><surname>Granato</surname><given-names>M</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name><name><surname>Mullins</surname><given-names>MC</given-names></name><name><surname>Hammerschmidt</surname><given-names>M</given-names></name></person-group><article-title>The identification of genes with unique and essential functions in the development of the zebrafish, <italic>Danio rerio</italic></article-title><source>Development</source><year>1996</year><volume>123</volume><fpage>1</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">9007226</pub-id></citation></ref><ref id="pbio-0030254-b39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pickart</surname><given-names>MA</given-names></name><name><surname>Sivasubbu</surname><given-names>S</given-names></name><name><surname>Nielsen</surname><given-names>AL</given-names></name><name><surname>Shriram</surname><given-names>S</given-names></name><name><surname>King</surname><given-names>RA</given-names></name></person-group><article-title>Functional genomics tools for the analysis of zebrafish pigment</article-title><source>Pigment Cell Res</source><year>2004</year><volume>17</volume><fpage>461</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">15357832</pub-id></citation></ref><ref id="pbio-0030254-b40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Golling</surname><given-names>G</given-names></name><name><surname>Amsterdam</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Antonelli</surname><given-names>M</given-names></name><name><surname>Maldonado</surname><given-names>E</given-names></name></person-group><article-title>Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development</article-title><source>Nat Genet</source><year>2002</year><volume>31</volume><fpage>135</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">12006978</pub-id></citation></ref><ref id="pbio-0030254-b41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>AY</given-names></name><name><surname>Mendenhall</surname><given-names>EM</given-names></name><name><surname>Kwan</surname><given-names>TT</given-names></name><name><surname>Liang</surname><given-names>R</given-names></name><name><surname>Eckfeldt</surname><given-names>C</given-names></name></person-group><article-title>Characterization of expanded intermediate cell mass in zebrafish chordin morphant embryos</article-title><source>Dev Biol</source><year>2005</year><volume>277</volume><fpage>235</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">15572152</pub-id></citation></ref><ref id="pbio-0030254-b42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hammerschmidt</surname><given-names>M</given-names></name><name><surname>Pelegri</surname><given-names>F</given-names></name><name><surname>Mullins</surname><given-names>MC</given-names></name><name><surname>Kane</surname><given-names>DA</given-names></name><name><surname>van Eeden</surname><given-names>FJ</given-names></name></person-group><article-title>Dino and mercedes, two genes regulating dorsal development in the zebrafish embryo</article-title><source>Development</source><year>1996</year><volume>123</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">9007232</pub-id></citation></ref><ref id="pbio-0030254-b43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Hernandez</surname><given-names>LD</given-names></name><name><surname>Galan</surname><given-names>JE</given-names></name><name><surname>Janeway</surname><given-names>CA</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group><article-title><italic>IRAK-M</italic> is a negative regulator of toll-like receptor signaling</article-title><source>Cell</source><year>2002</year><volume>110</volume><fpage>191</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">12150927</pub-id></citation></ref><ref id="pbio-0030254-b44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forster</surname><given-names>R</given-names></name><name><surname>Schubel</surname><given-names>A</given-names></name><name><surname>Breitfeld</surname><given-names>D</given-names></name><name><surname>Kremmer</surname><given-names>E</given-names></name><name><surname>Renner-Muller</surname><given-names>I</given-names></name></person-group><article-title>CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs</article-title><source>Cell</source><year>1999</year><volume>99</volume><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">10520991</pub-id></citation></ref><ref id="pbio-0030254-b45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilmour</surname><given-names>DT</given-names></name><name><surname>Lyon</surname><given-names>GJ</given-names></name><name><surname>Carlton</surname><given-names>MB</given-names></name><name><surname>Sanes</surname><given-names>JR</given-names></name><name><surname>Cunningham</surname><given-names>JM</given-names></name></person-group><article-title>Mice deficient for the secreted glycoprotein <italic>SPARC</italic>/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens</article-title><source>EMBO J</source><year>1998</year><volume>17</volume><fpage>1860</fpage><lpage>1870</lpage><pub-id pub-id-type="pmid">9524110</pub-id></citation></ref><ref id="pbio-0030254-b46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chida</surname><given-names>K</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name><name><surname>Hirai</surname><given-names>T</given-names></name><name><surname>Konishi</surname><given-names>C</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name></person-group><article-title>Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis</article-title><source>Cancer Res</source><year>2003</year><volume>63</volume><fpage>2404</fpage><lpage>2408</lpage><pub-id pub-id-type="pmid">12750259</pub-id></citation></ref><ref id="pbio-0030254-b47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brun</surname><given-names>AC</given-names></name><name><surname>Bjornsson</surname><given-names>JM</given-names></name><name><surname>Magnusson</surname><given-names>M</given-names></name><name><surname>Larsson</surname><given-names>N</given-names></name><name><surname>Leveen</surname><given-names>P</given-names></name></person-group><article-title>Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells</article-title><source>Blood</source><year>2004</year><volume>103</volume><fpage>4126</fpage><lpage>4133</lpage><pub-id pub-id-type="pmid">14962901</pub-id></citation></ref><ref id="pbio-0030254-b48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furthauer</surname><given-names>M</given-names></name><name><surname>Reifers</surname><given-names>F</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name><name><surname>Thisse</surname><given-names>C</given-names></name></person-group><article-title><italic>Sprouty4</italic> acts in vivo as a feedback-induced antagonist of FGF signaling in zebrafish</article-title><source>Development</source><year>2001</year><volume>128</volume><fpage>2175</fpage><lpage>2186</lpage><pub-id pub-id-type="pmid">11493538</pub-id></citation></ref><ref id="pbio-0030254-b49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>MA</given-names></name><name><surname>Ransom</surname><given-names>DG</given-names></name><name><surname>Pratt</surname><given-names>SJ</given-names></name><name><surname>MacLennan</surname><given-names>H</given-names></name><name><surname>Kieran</surname><given-names>MW</given-names></name></person-group><article-title>The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis</article-title><source>Dev Biol</source><year>1998</year><volume>197</volume><fpage>248</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">9630750</pub-id></citation></ref><ref id="pbio-0030254-b50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Bar-Sagi</surname><given-names>D</given-names></name></person-group><article-title>Modulation of signalling by <italic>Sprouty</italic> A developing story</article-title><source>Nat Rev Mol Cell Biol</source><year>2004</year><volume>5</volume><fpage>441</fpage><lpage>450</lpage><pub-id pub-id-type="pmid">15173823</pub-id></citation></ref><ref id="pbio-0030254-b51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brekken</surname><given-names>RA</given-names></name><name><surname>Sage</surname><given-names>EH</given-names></name></person-group><article-title>SPARC, a matricellular protein: At the crossroads of cell-matrix communication</article-title><source>Matrix Biol</source><year>2001</year><volume>19</volume><fpage>816</fpage><lpage>827</lpage><pub-id pub-id-type="pmid">11223341</pub-id></citation></ref><ref id="pbio-0030254-b52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>F</given-names></name><name><surname>Charnay</surname><given-names>P</given-names></name></person-group><article-title>Hindbrain patterning: FGFs regulate <italic>Krox20</italic> and <italic>mafB/kr</italic> expression in the otic/preotic region</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>4925</fpage><lpage>4935</lpage><pub-id pub-id-type="pmid">11044406</pub-id></citation></ref></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>BM</term><def><p>bone marrow</p></def></def-item><def-item><term>EGFP</term><def><p>enhanced green fluorescent protein</p></def></def-item><def-item><term>FGF</term><def><p>fibroblast growth factor</p></def></def-item><def-item><term>HPC</term><def><p>hematopoietic progenitor cell</p></def></def-item><def-item><term>hpf</term><def><p>hours postfertilization</p></def></def-item><def-item><term>HSC</term><def><p>hematopoietic stem cell</p></def></def-item><def-item><term>ICM</term><def><p>intermediate cell mass</p></def></def-item><def-item><term>MHC</term><def><p>major histocompatibility complex</p></def></def-item><def-item><term>ML&#x02013;IC</term><def><p>myeloid&#x02013;lymphoid initiating cell</p></def></def-item><def-item><term>MO</term><def><p>morpholino antisense oligonucleotide</p></def></def-item><def-item><term>Q-RT-PCR</term><def><p>quantitative RT-PCR</p></def></def-item><def-item><term>Rho</term><def><p>rhodamine</p></def></def-item><def-item><term>SCID</term><def><p>severe combined immunodeficiency</p></def></def-item><def-item><term>TF</term><def><p>transcription factor</p></def></def-item><def-item><term>Tg</term><def><p>transgenic</p></def></def-item><def-item><term>UCB</term><def><p>umbilical cord blood</p></def></def-item></def-list></glossary><fn-group><fn id="n2" fn-type="other"><p>Citation: Eckfeldt CE, Mendenhall EM, Flynn CM, Wang TF, Pickart MA, et al. (2005) Functional analysis of human hematopoietic stem cell gene expression using zebrafish. PLoS Biol 3(8): e254.</p></fn></fn-group><sec sec-type="display-objects"><title>Figures and Table</title><fig id="pbio-0030254-g001" position="float"><label>Figure 1</label><caption><title>Fluorescence-Activated Cell Sorting and Gene Expression Analysis</title><p>UCB or adult BM CD34<sup>+</sup>CD33<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup>Rho<sup>lo</sup>c-kit<sup>+</sup> (Rho<sup>lo</sup>; stem cell enriched) and CD34<sup>+</sup>CD33<sup>&#x02212;</sup>CD38<sup>&#x02212;</sup>Rho<sup>hi</sup> (Rho<sup>hi</sup>; stem cell depleted) cell populations were sorted for subsequent global gene expression profiling. Total RNA was isolated from Rho<sup>lo</sup> and Rho<sup>hi</sup> cell populations prior to linear amplification and labeling for hybridization to the Affymetrix HG-U133 GeneChip set (approximately 45,000 probe sets) and subsequent data analysis.</p></caption><graphic xlink:href="pbio.0030254.g001"/></fig><fig id="pbio-0030254-g002" position="float"><label>Figure 2</label><caption><title>Functional Genomics Screen in Zebrafish</title><p>The hematopoietic function of differentially expressed candidate genes was determined by injecting MOs into one- to two-cell embryos from <italic>gata1:</italic>DsRed Tg zebrafish to disrupt gene expression. Injected embryos were scored at 30&#x02013;48 hpf for the presence of DsRed<sup>+</sup> blood cells by fluorescence microscopy. Subsequently, MO-targeted embryos with gross hematopoietic defects were analyzed for the expression of the early hematopoietic markers <italic>gata1</italic> and <italic>scl</italic> by whole-mount in situ hybridization, and the late hematopoietic markers <italic>hbae1</italic> and <italic>lcp1</italic> by Q-RT-PCR.</p></caption><graphic xlink:href="pbio.0030254.g002"/></fig><fig id="pbio-0030254-g003" position="float"><label>Figure 3</label><caption><title>Representative Hematopoietic Phenotypes Observed in MO-Targeted Zebrafish Fluorescence microscopic images of <italic>gata1</italic>:DsRed Tg zebrafish embryos display the hematopoietic phenotypes observed for six MO-targeted zebrafish embryos compared to an uninjected control</title><p>Phenotypes shown are representative of greater than 70&#x00025; of injected embryos at 48 hpf (greater than or equal to three experiments of <italic>n</italic> &#x0003e; 40 embryos). Hematopoietic defects were quantified by Q-RT-PCR for the expression of erythroid-specific <italic>hbae1</italic> and myeloid-specific <italic>lcp1</italic> transcripts in MO-targeted embryos relative to uninjected clutchmate controls (greater than or equal to three experiments of <italic>n</italic> = 5 embryos; &#x0002a; <italic>p</italic> &#x0003c; 0.05)</p></caption><graphic xlink:href="pbio.0030254.g003"/></fig><fig id="pbio-0030254-g004" position="float"><label>Figure 4</label><caption><title>spry4 Is Required for Normal Hematopoietic Development in Zebrafish Embryos</title><p>(A) The observed frequency of hematopoietic defects in <italic>gata1:</italic>DsRed Tg zebrafish embryos are indicated for two independent <italic>spry4</italic>-targeted MOs (MO1 and MO2; black bars), a four-base mismatched control MO (MM MO; no bar indicates a 0&#x00025; frequency), a low-dose injection of MO1 and MO2 individually and in combination (gray bars), and MO2 coinjected with a human <italic>SPRY1</italic> DNA expression vector or a GFP control (white bars) (error bars = standard deviation of the mean, &#x0002a;<italic>p</italic> &#x0003c; 0.05, &#x0002a;&#x0002a;<italic>p</italic> &#x02264; 0.01).</p><p>(B) Representative pictures of the phenotypes seen with <italic>spry4</italic> MO1 at 48 h using <italic>fli1:</italic>EGFP/<italic>gata1:</italic>DsRed double Tg zebrafish embryos that have EGFP<sup>+</sup> vascular endothelial cells and DsRed<sup>+</sup> erythroid cells. The embryos display a more drastic reduction in DsRed<sup>+</sup> blood cells with some blood pooling and pericardial edema at higher MO doses (++MO) without major vasculature defects. The <italic>gata1:</italic>DsRed and <italic>fli1:</italic>EGFP Tg images are representative of three experiments of <italic>n</italic> &#x0003e; 40 embryos each.</p><p>(C) Q-RT-PCR analysis of <italic>hbae1</italic> and <italic>lcp1</italic> transcripts in <italic>spry4</italic> MO1, control mismatch MO and a <italic>gata1</italic> MO-injected zebrafish at 48 hpf (&#x0002a;<italic>p</italic> &#x0003c; 0.05).</p><p>(D) Injection of 30 pg of human <italic>SPRY1</italic> DNA expression vector resulted in an expansion of DsRed<sup>+</sup> hematopoietic cells in the posterior ICM in greater than 50&#x00025; of successfully injected embryos at 32 hpf (three experiments of <italic>n</italic> = 30), and a representative bright-field image is pictured with the fluorescence micrograph overlaid (left). Q-RT-PCR analysis of <italic>hbae1</italic> and <italic>lcp1</italic> transcripts in <italic>SPRY1</italic> overexpressing embryos relative to uninjected clutchmate controls (three experiments of <italic>n</italic> = 5 embryos) (right).</p></caption><graphic xlink:href="pbio.0030254.g004"/></fig><fig id="pbio-0030254-g005" position="float"><label>Figure 5</label><caption><title>spry4 Is Required for Early Hematopoietic Development, but Not Mesodermal Commitment, in Developing Zebrafish Embryos</title><p>(A) Expression of the early hematopoietic marker <italic>scl</italic> was reduced at the four-somite stage (arrow) and virtually absent at the 20-somite stage in spry4<sup>MO</sup> embryos compared to uninjected controls.</p><p>(B) The more mature hematopoietic marker <italic>gata1</italic> was also reduced in spry4<sup>MO</sup> compared to uninjected zebrafish embryos at 20 somites.</p><p>(C and D) In contrast to hematopoietic genes, the mesodermal-specific <italic>flk1</italic> (vasculature) transcripts were expressed at similar levels to uninjected controls at 26 hpf, and <italic>myod</italic> (muscle) had a slight defect (arrowhead) at 10 hpf, while expression was similar to controls at 26 hpf. All images are representative of greater than or equal to two experiments of <italic>n</italic> &#x02265; 8 embryos.</p></caption><graphic xlink:href="pbio.0030254.g005"/></fig><table-wrap id="pbio-0030254-t001" position="float"><label>Table 1</label><caption><title>Genes Differentially Expressed between Human Rho<sup>lo</sup> and Rho<sup>hi</sup> Cell Populations That Have a Functional Role in Zebrafish Hematopoietic Development</title></caption><graphic xlink:href="pbio.0030254.t001"/></table-wrap></sec></back></article> 